Health Care: Drugs

Arena Pharmaceuticals Inc (ARNA: NASDAQ)

$1.72 -0.05 | -2.82%
04/29/16 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 1.77
52 Week High 5.12
52 Week Low 1.30
Avg. Daily Vol. (Mil) 2.01
Beta (3 year) 1.45
Share Related Items
Mkt Cap (Mil) 429.88
Shares Out (Mil) 242.87
Float (Mil) 211.70
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.20
Current Ratio 3.50
LT Debt/ Equity 1.22
Total Debt / Equity 1.27
Valuation Ratios
Price Earnings n.a.
Price/Sales 11.22
Price/Book 8.03
Price/Cash Flow -4.40
Per Share Data
Earnings -0.45
Sales 0.16
Book Value 0.22
Cash Flow -0.40
Business Summary
Arena Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs.
General Information
6154 Nancy Ridge Drive
San Diego, CA 92121
Industry : Drugs
Sector: Health Care
Employees: 228
CEO: Dr. Harry F. Hixson, Jr
Short Interest
Current Month (Mil) 17.02
Previous Month (Mil) 19.16
Short Interest Ratio (Days) 7.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -42.00
Return on Investments -90.90
Gross Margin 92.20
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ARNA

Latest ARNA Headlines from TheStreet

More Financial News for ARNA

Press Releases for ARNA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter